ShwachmanBodianDiamond

Shwachman-Diamond syndrome, often abbreviated as SDS, is a rare genetic disorder characterized by a triad of symptoms: exocrine pancreatic insufficiency, bone marrow dysfunction, and skeletal abnormalities. The exocrine pancreatic insufficiency leads to malabsorption of nutrients, causing failure to thrive, steatorrhea (fatty stools), and abdominal distension. Bone marrow dysfunction can manifest as neutropenia, anemia, and thrombocytopenia, increasing the risk of recurrent infections and bleeding. Skeletal abnormalities may include metaphyseal chondrodysplasia, a type of bone disorder affecting the growth plates, leading to short stature and limb deformities.

SDS is caused by mutations in the Shwachman-Bodian-Diamond syndrome gene (SBDS). The inheritance pattern is autosomal recessive, meaning an individual must inherit two copies of the mutated gene, one from each parent, to develop the condition. Diagnosis is typically made based on clinical presentation, laboratory tests assessing pancreatic and bone marrow function, and genetic testing to confirm SBDS mutations.

Management of SDS is supportive and aims to address the specific complications. Nutritional support is crucial due to pancreatic insufficiency, often involving pancreatic enzyme replacement therapy and vitamin supplementation. Blood transfusions may be required for severe anemia or thrombocytopenia, and prophylactic antibiotics can help prevent infections in individuals with neutropenia. Regular monitoring for complications, including the increased risk of myelodysplastic syndrome and acute myeloid leukemia, is essential. The prognosis varies depending on the severity of the bone marrow dysfunction and the development of hematological malignancies.